Brokerages Set Definitive Healthcare Corp. (NASDAQ:DH) PT at $5.72

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been assigned an average recommendation of “Hold” from the twelve ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $5.72.

DH has been the topic of a number of research reports. Stephens started coverage on Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price objective on the stock. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. Finally, BTIG Research initiated coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 target price on the stock.

Definitive Healthcare Price Performance

DH opened at $4.11 on Friday. The business has a 50 day moving average of $4.37 and a 200-day moving average of $4.60. The stock has a market capitalization of $474.80 million, a price-to-earnings ratio of -1.33, a P/E/G ratio of 3.29 and a beta of 1.40. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62.

Insider Buying and Selling

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 14.84% of the stock is owned by insiders.

Hedge Funds Weigh In On Definitive Healthcare

Institutional investors have recently modified their holdings of the business. Massachusetts Financial Services Co. MA lifted its holdings in shares of Definitive Healthcare by 36.8% in the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after purchasing an additional 1,626,813 shares in the last quarter. Millennium Management LLC bought a new stake in Definitive Healthcare in the 2nd quarter valued at approximately $9,283,000. State Street Corp boosted its position in Definitive Healthcare by 29.4% during the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after acquiring an additional 317,952 shares during the last quarter. 272 Capital LP grew its stake in shares of Definitive Healthcare by 74.8% during the 3rd quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock worth $4,980,000 after acquiring an additional 476,766 shares in the last quarter. Finally, Granite Investment Partners LLC raised its holdings in shares of Definitive Healthcare by 22.5% in the second quarter. Granite Investment Partners LLC now owns 884,872 shares of the company’s stock valued at $4,831,000 after purchasing an additional 162,432 shares during the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.